Regulatory & Legal

Colorectal cancer is the #1 cancer killer for adults under 50. A new study reveals a shocking awareness gap that is fueling this growing public health crisis.

Lithuania's grid operator reports higher revenue but lower profit, while adjusted figures show strength. The results underscore a pivotal year of European integration.

Kitchen equipment maker Li Bang International is acquiring a major caterer, a bold move to nearly double its revenue and dive into China's booming food service market.

Former FHA Commissioner Brian Montgomery's move to NewDay USA signals a strategic play to deepen its service to veterans in a complex housing market.

A $2.5B private project gets the green light to build a subsea cable, promising to end Puerto Rico's blackouts and forge a new era of Caribbean energy.

With new funding and veteran US leadership, UK-based OSSTEC is preparing to launch its innovative ASCENT partial knee system in a competitive market.

Trump Media plans a complex deal to spin off Truth Social after its fusion energy merger, aiming to create two distinct publicly traded companies.

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

The global Edtech firm's prestigious accreditation signals a new era of accountability, forcing a reckoning on quality in the online tutoring market.

Two college students are set to pitch their record-breaking material science innovation on ABC's Shark Tank, starting with a product you use every day.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

A new technology bypasses device makers to give networks unprecedented control of location data, promising to power a new economy of 'Physical AI'.

Childhelp co-founder Sara O'Meara receives a lifetime achievement award, highlighting a new partnership and the ongoing fight to protect vulnerable children.

Despite a dip in annual profits, Boralex commissions major UK and Canadian projects, showcasing financial resilience and commitment to its 2030 growth plan.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.

A new lawsuit from a rival CEO puts Jura Energy's Pakistani assets in the crosshairs, escalating a feud rooted in a multi-million dollar arbitration.

At a UN event, Beijing launched a book on its governance model and promoted its Global Governance Initiative, signaling a push to reshape international order.

Graphite One's new tradable warrants aim to fund a vital domestic graphite project, but investors face a long road from financial maneuver to production.

After a challenging year, InTest Corp. posts a strong Q4 rebound, driven by growth in non-semi markets. A robust backlog signals a promising 2026.

The biopharma firm beats 2025 guidance on strong specialty and generic sales, forecasting another year of growth fueled by new product launches.